Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease (K-ELUVIA Registry)

Inclusion Criteria: * Age 19 years of older * Symptomatic peripheral artery disease: Moderate or severe claudication (Rutherford category 2 or 3) and Critical limb ischemia (Rutherford category 4-5) * Femoropopliteal artery lesions with stenosis \> 50% * ABI \< 0.9 before treatment * Patents treated with ELUVIA stent for femoropopliteal artery disease * Patients with signed informed consent Exclusion Criteria: * Acute critical limb ischemia * Severe critical limb ischemia (Rutherford category 6) * Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, cilostazol, or contrast agents * In-stent restenosis lesions (Restenosis lesions without previously implanted stents are eligible to the enrollment) * Bypass graft lesions * Age \> 85 years * Severe hepatic dysfunction (\> 3 times normal reference values) * Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis * LVEF \< 40% or clinically overt congestive heart failure * Pregnant women or women with potential childbearing * Life expectancy \<1 year due to comorbidity * Untreated proximal inflow disease of the ipsilateral iliac arteries (more than 50% stenosis or occlusion)